Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/1481

TR 380 Mouse Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                          EPINEPHRINE HCL


NTP Experiment-Test: 05095-02                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/13/94
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54




       Facility:  Battelle Northwest

       Chemical CAS #:  55-31-2

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Dead                                              11            7            9                                                  
    Moribund                                           7            8            7                                                  
  Survivors                                                                                                                         
    Moribund                                                                     1                                                  
    Terminal Sacrifice                                32           35           33                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (47)         (15)         (48)                                                
      Dilatation                                                    1 (7%)                                                          
   Intestine Large, Colon                             (49)         (15)         (50)                                                
      Inflammation, Chronic                                         1 (7%)                                                          
   Intestine Large, Rectum                            (50)         (15)         (50)                                                
      Prolapse                                                      1 (7%)                                                          
   Intestine Small, Ileum                             (49)         (14)         (50)                                                
      Amyloid Deposition                               1 (2%)                                                                       
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
   Intestine Small, Jejunum                           (49)         (18)         (50)                                                
      Inflammation, Suppurative                                     1 (6%)                                                          
   Liver                                              (50)         (20)         (50)                                                
      Cyst                                             2 (4%)                                                                       
      Cytologic Alterations                                         1 (5%)                                                          
      Focal Cellular Change                                         1 (5%)       2 (4%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Infarct                                          1 (2%)                                                                       
      Infiltration Cellular, Lymphocyte                1 (2%)                    1 (2%)                                             
      Inflammation, Subacute                           2 (4%)                    3 (6%)                                             
      Necrosis                                         3 (6%)                    1 (2%)                                             
   Pancreas                                           (50)         (16)         (50)                                                
      Inflammation, Subacute                           1 (2%)                                                                       
      Acinus, Hypoplasia                                                         1 (2%)                                             
      Duct, Cyst                                                                 1 (2%)                                             
   Salivary Glands                                    (49)         (14)         (49)                                                
      Hemorrhage                                                    1 (7%)                                                          
   Stomach, Forestomach                               (50)         (19)         (49)                                                
      Hyperkeratosis                                   6 (12%)      1 (5%)       3 (6%)                                             
      Hyperplasia, Lymphoid                                         1 (5%)                                                          
      Inflammation, Subacute                                                     1 (2%)                                             
      Inflammation, Suppurative                                                  1 (2%)                                             
      Ulcer                                                         1 (5%)       1 (2%)                                             
      Epithelium, Hyperplasia                                       1 (5%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Stomach, Glandular                                 (50)         (15)         (50)                                                
      Hyperplasia                                      3 (6%)                                                                       
      Inflammation, Subacute                           1 (2%)                                                                       
      Mineralization                                   1 (2%)                    1 (2%)                                             
      Pigmentation                                     1 (2%)                                                                       
   Tooth                                              (1)                       (3)                                                 
      Abscess                                          1 (100%)                                                                     
      Developmental Malformation                                                 3 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (15)         (50)                                                
      Atrium, Thrombosis                               1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (16)         (50)                                                
      Hyperplasia                                                                1 (2%)                                             
      Hyperplasia, Focal                               1 (2%)                    1 (2%)                                             
      Hypertrophy, Focal                               2 (4%)       1 (6%)       1 (2%)                                             
   Adrenal Gland, Medulla                             (50)         (16)         (50)                                                
      Hyperplasia                                      1 (2%)       1 (6%)       2 (4%)                                             
   Pituitary Gland                                    (49)         (46)         (49)                                                
      Congestion                                       4 (8%)       1 (2%)       1 (2%)                                             
      Hyperplasia                                     18 (37%)     17 (37%)     22 (45%)                                            
      Pigmentation                                                  1 (2%)                                                          
      Pars Distalis, Hyperplasia                                    1 (2%)                                                          
      Pars Intermedia, Hyperplasia                     1 (2%)                                                                       
   Thyroid Gland                                      (49)         (18)         (48)                                                
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Inflammation, Chronic                                         1 (6%)                                                          
      Follicular Cell, Cyst                                         1 (6%)                                                          
      Follicular Cell, Hyperplasia                     4 (8%)                    6 (13%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (50)         (26)         (50)                                                
      Corpora Amylacea                                 1 (2%)                                                                       
      Cyst                                            18 (36%)     12 (46%)     11 (22%)                                            
      Cyst, Multiple                                                1 (4%)                                                          
      Hemorrhage                                                                 1 (2%)                                             
      Mineralization                                                2 (8%)                                                          
      Pigmentation                                                  1 (4%)                                                          
      Germinal Epithelium, Hyperplasia                              1 (4%)                                                          
      Rete Ovarii, Hyperplasia                                                   1 (2%)                                             
   Uterus                                             (50)         (19)         (50)                                                
      Angiectasis                                                                1 (2%)                                             
      Dilatation                                       1 (2%)       1 (5%)                                                          
      Hyperplasia, Cystic                              1 (2%)                                                                       
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Prolapse                                                                   1 (2%)                                             
      Thrombosis                                                                 1 (2%)                                             
      Artery, Thrombosis                                                         1 (2%)                                             
      Endometrium, Degeneration, Hyaline               1 (2%)                                                                       
      Endometrium, Hyperplasia                         8 (16%)      1 (5%)       8 (16%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (15)         (50)                                                
      Myelofibrosis                                    2 (4%)                    1 (2%)                                             
   Lymph Node                                         (50)         (29)         (49)                                                
      Iliac, Hyperplasia, Lymphoid                                  1 (3%)       1 (2%)                                             
      Mediastinal, Hyperplasia, Lymphoid                                         1 (2%)                                             
      Mesenteric, Congestion                           1 (2%)       1 (3%)                                                          
      Mesenteric, Hyperplasia, Lymphoid                2 (4%)                                                                       
      Renal, Hyperplasia, Lymphoid                                               2 (4%)                                             
   Lymph Node, Bronchial                              (45)         (20)         (49)                                                
      Hyperplasia, Lymphoid                                         3 (15%)      1 (2%)                                             
   Lymph Node, Mandibular                             (49)         (19)         (45)                                                
      Atrophy                                                                    1 (2%)                                             
      Hyperplasia, Lymphoid                                         3 (16%)      7 (16%)                                            
      Pigmentation                                     1 (2%)                    1 (2%)                                             
   Spleen                                             (50)         (25)         (50)                                                
      Atrophy                                                                    2 (4%)                                             
      Hematopoietic Cell Proliferation                 4 (8%)       2 (8%)                                                          
      Hyperplasia, Histiocytic                         1 (2%)                                                                       
      Hyperplasia, Lymphoid                            4 (8%)       3 (12%)      5 (10%)                                            
      Inflammation, Granulomatous                                                1 (2%)                                             
      Inflammation, Suppurative                                     1 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (44)         (14)         (45)                                                
      Duct, Dilatation, Multifocal                                               1 (2%)                                             
   Skin                                               (49)         (23)         (49)                                                
      Alopecia                                         5 (10%)      6 (26%)      6 (12%)                                            
      Edema                                                         1 (4%)       2 (4%)                                             
      Inflammation, Chronic                                         1 (4%)       1 (2%)                                             
      Inflammation, Necrotizing                                     1 (4%)       1 (2%)                                             
      Ulcer                                                                      1 (2%)                                             
      Sebaceous Gland, Hyperplasia                                  1 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (15)         (50)                                                
      Costochondral Junction, Degeneration                                       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (15)         (50)                                                
      Hemorrhage, Acute, Multifocal                                 1 (7%)                                                          
      Inflammation, Subacute                           1 (2%)                                                                       
      Mineralization                                   9 (18%)      3 (20%)     16 (32%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (27)         (50)                                                
      Congestion                                                                 1 (2%)                                             
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Infiltration Cellular, Lymphocyte                2 (4%)       1 (4%)       1 (2%)                                             
      Infiltration Cellular, Histiocyte                                          1 (2%)                                             
      Inflammation, Granulomatous                      5 (10%)      2 (7%)       3 (6%)                                             
      Inflammation, Subacute                           2 (4%)       1 (4%)       1 (2%)                                             
      Thrombosis                                                    2 (7%)                                                          
      Alveolar Epithelium, Hyperplasia                 2 (4%)       2 (7%)       1 (2%)                                             
      Interstitium, Fibrosis                           1 (2%)                                                                       
   Nose                                               (50)         (48)         (50)                                                
      Inflammation, Suppurative                        1 (2%)       7 (15%)      8 (16%)                                            
      Olfactory Epithelium, Degeneration, Hyaline     44 (88%)     43 (90%)     47 (94%)                                            
      Olfactory Epithelium, Metaplasia                 1 (2%)                                                                       
      Olfactory Epithelium, Metaplasia, Focal         10 (20%)     21 (44%)     12 (24%)                                            
      Respiratory Epithelium, Degeneration             1 (2%)                                                                       
      Respiratory Epithelium, Degeneration, Hyaline    7 (14%)     28 (58%)     19 (38%)                                            
      Respiratory Epithelium, Metaplasia, Squamous                               1 (2%)                                             
      Respiratory Epithelium, Necrosis                                           1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (19)         (50)                                                
      Cyst                                             1 (2%)                    1 (2%)                                             
      Hemorrhage, Acute                                             1 (5%)                                                          
      Hydronephrosis                                   1 (2%)       1 (5%)                                                          
      Inflammation, Subacute                           1 (2%)                    2 (4%)                                             
      Metaplasia, Osseous                              1 (2%)                                                                       
      Glomerulus, Amyloid Deposition                   1 (2%)                                                                       
      Renal Tubule, Degeneration, Hyaline                           1 (5%)                                                          
   Urinary Bladder                                    (50)         (15)         (50)                                                
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Dead                                              10            4            4                                                  
    Moribund                                           7           12           10                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                33           34           36                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Rectum                            (50)         (15)         (50)                                                
      Inflammation, Suppurative                                                  1 (2%)                                             
   Intestine Small                                    (50)         (18)         (50)                                                
      Peyer's Patch, Hyperplasia, Lymphoid                                       1 (2%)                                             
   Intestine Small, Ileum                             (50)         (17)         (49)                                                
      Amyloid Deposition                                                         1 (2%)                                             
      Hyperplasia, Lymphoid                                         1 (6%)                                                          
   Intestine Small, Jejunum                           (50)         (17)         (50)                                                
      Hyperplasia, Lymphoid                                         1 (6%)       1 (2%)                                             
   Liver                                              (50)         (25)         (50)                                                
      Congestion                                       1 (2%)                                                                       
      Focal Cellular Change                            1 (2%)       1 (4%)       1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Infarct                                          1 (2%)       1 (4%)       3 (6%)                                             
      Inflammation, Subacute                                        1 (4%)       1 (2%)                                             
      Necrosis                                         1 (2%)       2 (8%)                                                          
      Bile Duct, Cyst                                                            1 (2%)                                             
      Serosa, Fibrosis, Chronic                                     1 (4%)                                                          
   Pancreas                                           (50)         (16)         (50)                                                
      Hemorrhage                                                                 1 (2%)                                             
      Duct, Cyst                                       1 (2%)                                                                       
   Stomach, Forestomach                               (47)         (16)         (50)                                                
      Hyperkeratosis                                                1 (6%)       2 (4%)                                             
      Inflammation, Subacute                           1 (2%)                    1 (2%)                                             
      Ulcer                                                                      1 (2%)                                             
   Stomach, Glandular                                 (49)         (16)         (50)                                                
      Hyperplasia                                      2 (4%)       1 (6%)       2 (4%)                                             
      Subserosa, Cyst                                  1 (2%)                                                                       
   Tooth                                              (2)                       (1)                                                 
      Inflammation, Suppurative                        2 (100%)                  1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (16)         (50)                                                
      Artery, Inflammation, Subacute                   1 (2%)                                                                       
      Atrium, Thrombosis                                                         1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (32)         (48)                                                
      Hyperplasia                                                   1 (3%)       3 (6%)                                             
      Hyperplasia, Diffuse                                                       2 (4%)                                             
      Hyperplasia, Focal                               2 (4%)       4 (13%)      1 (2%)                                             
      Hypertrophy                                                   2 (6%)       3 (6%)                                             
      Hypertrophy, Diffuse                                          1 (3%)       3 (6%)                                             
      Hypertrophy, Focal                              16 (32%)     12 (38%)     13 (27%)                                            
   Adrenal Gland, Medulla                             (48)         (16)         (45)                                                
      Hyperplasia, Focal                               1 (2%)                                                                       
   Pituitary Gland                                    (50)         (16)         (48)                                                
      Cyst                                             1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Penis                                                           (2)                                                              
      Abscess                                                       1 (50%)                                                         
      Inflammation, Chronic                                         1 (50%)                                                         
   Preputial Gland                                    (13)         (9)          (7)                                                 
      Inflammation, Chronic                            1 (8%)       1 (11%)                                                         
      Inflammation, Suppurative                        5 (38%)      4 (44%)      4 (57%)                                            
      Duct, Dilatation                                 6 (46%)      4 (44%)      1 (14%)                                            
      Duct, Hyperplasia                                1 (8%)                                                                       
   Prostate                                           (48)         (13)         (49)                                                
      Inflammation, Suppurative                        2 (4%)       1 (8%)       1 (2%)                                             
   Seminal Vesicle                                    (2)          (4)          (1)                                                 
      Dilatation                                                    1 (25%)                                                         
      Inflammation, Chronic                            1 (50%)                                                                      
      Inflammation, Suppurative                        1 (50%)                                                                      
   Testes                                             (50)         (15)         (50)                                                
      Atrophy                                          1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (16)         (50)                                                
      Hyperplasia, Neutrophil                          1 (2%)       1 (6%)                                                          
   Lymph Node                                         (49)         (20)         (50)                                                
      Mediastinal, Hyperplasia, Lymphoid                            1 (5%)                                                          
      Mesenteric, Hyperplasia, Lymphoid                1 (2%)                                                                       
      Mesenteric, Sinus, Dilatation                                 1 (5%)                                                          
      Renal, Hyperplasia, Lymphoid                                  1 (5%)                                                          
   Lymph Node, Bronchial                              (43)         (13)         (49)                                                
      Hyperplasia, Lymphoid                                         1 (8%)       1 (2%)                                             
   Lymph Node, Mandibular                             (43)         (12)         (41)                                                
      Hyperplasia, Lymphoid                            3 (7%)                    2 (5%)                                             
   Spleen                                             (50)         (20)         (50)                                                
      Atrophy                                                       1 (5%)                                                          
      Hematopoietic Cell Proliferation                 3 (6%)       2 (10%)      1 (2%)                                             
      Hyperplasia, Lymphoid                                                      2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (48)         (21)         (49)                                                
      Alopecia                                         3 (6%)       4 (19%)      3 (6%)                                             
      Inflammation, Necrotizing                                                  1 (2%)                                             
      Inflammation, Suppurative                        2 (4%)       1 (5%)       1 (2%)                                             
      Subcutaneous Tissue, Inflammation, Chronic       2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (16)         (50)                                                
      Abscess                                                       1 (6%)                                                          
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Mineralization                                  30 (60%)      2 (13%)     31 (62%)                                            
      Meninges, Hyperplasia, Lymphoid                                            1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (32)         (50)                                                
      Congestion                                       2 (4%)                    2 (4%)                                             
      Hemorrhage, Acute                                             1 (3%)                                                          
      Hemorrhage, Focal                                                          4 (8%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Infiltration Cellular, Histiocyte                2 (4%)       3 (9%)                                                          
      Inflammation, Subacute                           4 (8%)       1 (3%)       2 (4%)                                             
      Inflammation, Suppurative                                     3 (9%)       1 (2%)                                             
      Leukocytosis                                                               1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 7 (14%)      6 (19%)      6 (12%)                                            
      Alveolar Epithelium, Hyperplasia, Focal          1 (2%)                    2 (4%)                                             
      Bronchiole, Hyperplasia                                                    2 (4%)                                             
      Bronchiole, Hyperplasia, Focal                                5 (16%)                                                         
      Bronchus, Ulcer, Focal                                                     1 (2%)                                             
      Pleura, Inflammation, Subacute                   1 (2%)                                                                       
   Nose                                               (50)         (50)         (50)                                                
      Hemorrhage, Acute                                             1 (2%)                                                          
      Inflammation, Suppurative                        1 (2%)       4 (8%)       3 (6%)                                             
      Nasolacrimal Duct, Inflammation, Suppurative                  1 (2%)                                                          
      Olfactory Epithelium, Degeneration, Focal,                                                                                    
           Hyaline                                                               1 (2%)                                             
      Olfactory Epithelium, Degeneration, Hyaline      3 (6%)      17 (34%)     39 (78%)                                            
      Olfactory Epithelium, Metaplasia, Focal          8 (16%)     11 (22%)      8 (16%)                                            
      Respiratory Epithelium, Degeneration, Hyaline    5 (10%)      2 (4%)       2 (4%)                                             
      Respiratory Epithelium, Hyperplasia, Focal       1 (2%)       2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (16)         (50)                                                
      Atrophy                                                       1 (6%)                                                          
      Bacterium, Acute                                 1 (2%)                                                                       
      Developmental Malformation                                    1 (6%)                                                          
      Fibrosis, Focal                                  1 (2%)                                                                       
      Hemorrhage, Focal                                                          1 (2%)                                             
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Inflammation, Chronic, Focal                     1 (2%)                                                                       
      Inflammation, Suppurative                                     1 (6%)       1 (2%)                                             
      Metaplasia, Osseous                              1 (2%)                    1 (2%)                                             
      Mineralization                                                1 (6%)       1 (2%)                                             
      Nephropathy                                      1 (2%)                    1 (2%)                                             
      Pelvis, Inflammation, Chronic                    2 (4%)       2 (13%)      2 (4%)                                             
      Pelvis, Inflammation, Suppurative                             1 (6%)       1 (2%)                                             
      Renal Tubule, Casts                                                        2 (4%)                                             
      Renal Tubule, Degeneration                                                 2 (4%)                                             
      Renal Tubule, Dilatation                                                   1 (2%)                                             
      Renal Tubule, Regeneration                       3 (6%)                    3 (6%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05095-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                          EPINEPHRINE HCL                                      Date: 09/13/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 00:50:54  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          CONTROL      1.5MG/M3     3.0MG/M3                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Renal Tubule, Regeneration, Focal                1 (2%)                    1 (2%)                                             
   Urinary Bladder                                    (50)         (16)         (50)                                                
      Concretion                                       1 (2%)                                                                       
      Dilatation                                       1 (2%)       1 (6%)                                                          
      Hyperplasia                                                   1 (6%)                                                          
      Inflammation, Subacute                           1 (2%)       1 (6%)                                                          
      Inflammation, Suppurative                        1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 67634-67634/67634


--multipart-boundary--